VOYA Investment Management’s Structure Therapeutics GPCR Stock Holding History

VOYA Investment Management’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.14M	Sell	44,410 -10,890	-20%	-$745K	﹤0.01%	1149
2025 Q4	$3.85M	Buy	55,300 +38,875	+237%	+$1.59M	﹤0.01%	970
2025 Q3	$460K	Sell	16,425 -14,230	-46%	-$283K	﹤0.01%	1793
2025 Q2	$636K	Buy	30,655 +4,715	+18%	+$104K	﹤0.01%	1780
2025 Q1	$449K	Hold	25,940	–	–	﹤0.01%	1915
2024 Q4	$703K	Sell	25,940 -20,830	-45%	-$739K	﹤0.01%	1784
2024 Q3	$2.05M	Sell	46,770 -14,940	-24%	-$578K	﹤0.01%	1327
2024 Q2	$2.42M	Buy	+61,710	New	+$2.53M	﹤0.01%	1260
2024 Q1	–	Sell	-9,730	Closed	-$397K	–	2826
2023 Q4	$397K	Sell	9,730 -76,744	-89%	-$4.4M	﹤0.01%	2195
2023 Q3	$4.36M	Buy	+86,474	New	+$2.79M	﹤0.01%	1030

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

VOYA Investment Management's GPCR Position: Q1 2026 in Review

VOYA Investment Management reduced its Structure Therapeutics (GPCR) stake by 20% in Q1 2026, selling an estimated $745K and leaving 44,410 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1149.

VOYA Investment Management first reported a position in GPCR in Q3 2023 and has held it in 10 quarters since. The position peaked at $4.36M in Q3 2023. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

VOYA Investment Management held 44,410 shares of Structure Therapeutics worth $2.14M as of Q1 2026.
VOYA Investment Management sold 10,890 Structure Therapeutics shares in Q1 2026, an estimated $745K.
Structure Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1149 holding.
VOYA Investment Management first reported a position in Structure Therapeutics in Q3 2023 and has held it in 10 quarters since.
VOYA Investment Management's Structure Therapeutics position peaked at $4.36M in Q3 2023.
196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.